Title:
EDARAVONE DERIVATIVE AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2018/133621
Kind Code:
A1
Abstract:
An edaravone derivative and a use thereof. As compared with edaravone, the derivative has enhanced treatment effects and significantly reduced cytotoxicity.
Inventors:
ZHOU LELE (CN)
ZHOU XINFU (CN)
SHAN ZHENGNAN (CN)
ZHOU XINFU (CN)
SHAN ZHENGNAN (CN)
Application Number:
PCT/CN2017/117914
Publication Date:
July 26, 2018
Filing Date:
December 22, 2017
Export Citation:
Assignee:
ZHOU YI (CN)
International Classes:
C07D231/26; A61K31/4152; A61P9/10
Foreign References:
CN102180832A | 2011-09-14 | |||
CN102614171A | 2012-08-01 | |||
CN105616405A | 2016-06-01 | |||
US20100216853A1 | 2010-08-26 | |||
CN102648908A | 2012-08-29 |
Attorney, Agent or Firm:
CHINA SINDA INTELLECTUAL PROPERTY LTD. (CN)
Download PDF: